Drugs / Egito
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04970108 | Aug 2023 → Jan 2025 | hypertensive disorder, type 2 diabetes mellitus | EMS | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EGITO | “EGITO Egito coated tablet.” NCT04970108 ↗ |
| Route | Oral | “1 tablet Egito, oral;” NCT04970108 ↗ |